Oral and Subcutaneous Prostacyclin Analogs: Analyzing the Latest Evidence on Efficacy and Safety

Advances in Pulmonary Hypertension
doi 10.21693/1933-088x-1.3.11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pulmonary Hypertension Association

Related search

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator

Journal of Clinical Medicine
2018English

Update on the Development of Oral Prostacyclin Analogs for the Treatment of PAH

Advances in Pulmonary Hypertension
2009English

Efficacy, Safety and Clinical Use of Newer Basal Insulins Analogs

Endocrinology&Metabolism International Journal
2018English

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis

Allergy, Asthma and Immunology Research
ImmunologyPulmonaryAllergyRespiratory Medicine
2018English

The Safety and Efficacy of Sublingual and Oral Immunotherapy for Milk Allergy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2012English

Efficacy and Safety of Nucleoside Analogs on Blocking Father-To-Infant Vertical Transmission of Hepatitis B Virus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Latest Evidence on Sulfonylureas: What’s New?

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study

Pituitary
EndocrinologyMetabolismDiabetes
2019English

Efficacy and Safety of Tetrahydrocurcuminoid in the Treatment of Oral Leukoplakia: A Pilot Study

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy